1.1. General overview
The pharmaceutical industry is susceptible because it touches on the lives of the people directly.
The malpractices that occur in the industry should, therefore, be looked into and addressed. This
section will give information on the pharmaceutical industry, how it is run and an outline of the
cases of malpractices in the pharmaceutical industry in Pakistan with a focus on how they affect
the lives of the people in the society. The law is used in the protection of the clients from the
unscrupulous deals that threaten the lives of the people in the society.
1.2. Problem statement
This section outlined the underlying problem that affects the pharmaceutical industry in Pakistan.
It addresses the main problems that have led to the research. It will also show how the laws have
been put in place but are not effective in the society.
The study will focus on a total of six variables that are the cause of unethical pharmaceutical
marketing techniques in Pakistan, i.e. the doctor’s community, government and the private
hospital's personnel, pharmaceutical marketing and sales personnel, retail and wholesale
pharmacies, the government officials and patients or their attendants. The study will assess how
each valuable influences the malpractices by the pharmaceutical companies. Data will be
collected about the variables.
1.4. Rationale/ reasons for the study
The rationale of the study is the fact that the pharmaceutical industry is sensitive in the society
hence there is a need to address the malpractices. The research addresses the origin of the
malpractices so that they can be dealt with accordingly.
The general objective is to address the malpractice by the Pharmaceutical Companies and its
effects in Pakistan and address the way tort law can be used to curb the malpractices in the
H 0 : The malpractices in the pharmaceutical companies impede the achievement of quality
healthcare in Pakistan hence the tort law as well as the other laws should be used to fight it.
1.7. Research questions
What are the effects of malpractices in the pharmaceutical companies on the general health of the
MALPRACTICES IN THE PHARMACEUTICAL COMPANIES 3
What legal procedures has the government put in place to curb the incidences of malpractices in
the pharmaceutical companies?
Are the measures put in place to address the malpractices in the pharmaceutical companies
2. Literature review
The section contains the recent existing literature on the topic and how it is going to help in the
research. The section will also address the gap in research and how future research on the topic
will be done which includes how the legal aspect should be used to curb the malpractices.
3. Data collection
The researcher will conduct a literature search and then extract the data from the papers that have
been selected in the research. A literature search is a good source of secondary data that will be
beneficial in the research. It will give information on the research that has been conducted before
for the benefit of the society.
This section will expand on the data collected in the literature search. It will contain a detailed
account of the situation by making a comparison on what the society has done with regards to the
issue. One of the most important causes of malpractices is the intention of a given company to
make money as opposed to focusing on healthcare. The section will, therefore, link the data
found in the results with the research questions with the aim of meeting the objectives of the
research which is to address the malpractice by the Pharmaceutical Companies and its effects in
Malpractices it the pharmaceutical industry is one of the greatest impediment in the quest of
quality healthcare in the society. The conclusions will build on the statement above with the view
of the results that will be found in research. The conclusion will also be explained if the research
was successful or not and what can be done in the future with regards to the topic at hand.
This section recommends what can be done in society as a result of the findings of the research.
The following sources will be used together with the others as the research will demand.
Ahmed, R. R. (2012). Pharmaceutical Drug Promotion in Pakistan.
Yousafzai, A. W. (2015). Corruption in medical practice: Where do we stand?. Journal of Ayub
Medical College Abbottabad, 27(3), 515-516.
MALPRACTICES IN THE PHARMACEUTICAL COMPANIES 4
Rashid, H. (2015). Impact of the drug regulatory authorityPakistan: An evaluation. New Visions
for Public Affairs, 7, 50-61.